Study of HRS-2162 in Healthy Volunteers
This is a first-in-human study testing a single dose of an experimental drug called HRS-2162 in healthy volunteers. The study looks at how the drug is processed by the body and how safe it is.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 45 years old.
- You must be in good general health with no chronic or acute medical conditions.
- Your weight must be at least 110 pounds (50 kg) for men or 100 pounds (45 kg) for women, and your body mass index must be between 19 and 28.
- You must agree to use effective birth control during the study.
- You cannot have a history of bleeding disorders, muscle or nerve disease, or problems with anesthesia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety study of an experimental drug called HRS-7156 in people with no serious health conditions. Researchers will monitor how your body tolerates the drug and how it moves through your system.
This trial tests a new investigational drug called HRS-2183 in healthy volunteers to see how safe it is and how the body processes it after a single dose and after multiple doses. It's a first step in studying this potential medicine.
This is an early-stage safety test of a new experimental drug called HRS-5765 in people without serious health conditions. Researchers want to make sure the drug is safe and understand how your body processes it.
This study tests a new investigational drug called HRS-6257 in healthy volunteers. It looks at how the drug works in the body and checks for side effects after one or several doses.
This trial tests a single dose of a new medicine called HRS-4029 in healthy people. It helps doctors learn how the drug works in the body and if it is safe. Healthy adults aged 18 to 55 may be able to join.
This trial tests a new drug called HS-20136-2 in healthy people to see how it works in the body and if it's safe. It's a Phase 1 study to gather early information before testing in patients.
Hear when a new Reversal of Neuromuscular Blockade trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.